FIELD: medicine.
SUBSTANCE: invention relates to a method for mammal skin or mucosal tissue microbial infection treatment comprising administration of a therapeutically effective amount of a composition comprising at least one peptide of formula Pal-lipid-lysine-proline-NH2 or Pal-lipid-lysine-d-proline-NH2, and a pharmaceutically acceptable carrier for an effective amount of time to the infected area.
EFFECT: invention provides treatment of mammal skin or mucosal tissue microbial infections.
6 cl, 1 ex, 4 tbl
Authors
Dates
2017-08-09—Published
2013-03-07—Filed